Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Pain 3Neoplasms 3Marijuana Abuse 3Recurrence 1Parasomnias 1Pancreatic Neoplasms 1Nausea 1Glioblastoma 1Chronic Pain 1Cachexia 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1Advanced Malignant Solid Tumor 1

Interventions

nabiximols 3Cannabidiol 2Temozolomide 1Medical Marijuana 1Dronabinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Marijuana Abuse × nabiximols × Clear all
NCT05629702 2026-05-05

ARISTOCRAT

University of Birmingham

Phase 2 Recruiting
120 enrolled
CNS

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

NCT03245658 2023-12-18

The Effect of Cannabis in Pancreatic Cancer

University of Copenhagen

Phase 2 Withdrawn
Gastrointestinal

Anorexia, Cachexia, Marijuana Abuse, Neoplasms, Pancreatic Neoplasms

NCT03522467 2019-09-25

COPE

Aurora Cannabis Inc

Phase 2 Unknown
40 enrolled

Marijuana Abuse, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡